The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Molina Arturo Md since 2019.
This trader's CIK number is 1398940.
At the time of last reporting, Molina Arturo Md was the Chief Medical Officer of Protagonist Therapeutics, Inc. (stock ticker symbol PTGX).
Also see all insider trading activities at Protagonist Therapeutics, Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | STRO | 0 | $0 | 0 | $0 | 17,750 | $0 |
2021 | STRO | 0 | $0 | 0 | $0 | 13,859 | $0 |
2020 | STRO | 6,451 | $49,995 | 0 | $0 | 8,609 | $0 |
2019 | STRO | 0 | $0 | 0 | $0 | 8,608 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | PTGX | 0 | $0 | 54,154 | $2,826,250 | 50,514 | $1,112,834 |
2024 | PTGX | 0 | $0 | 35,283 | $1,521,530 | 31,529 | $253,492 |
1. Sutro Biopharma, Inc. (STRO)
2. Protagonist Therapeutics, Inc (PTGX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-03-05 | STRO | Option Ex | 12,500 | .00 | 0 |
2022-01-29 | STRO | Option Ex | 5,250 | .00 | 0 |
2021-09-24 | STRO | Option Ex | 8,609 | .00 | 0 |
2021-01-29 | STRO | Option Ex | 5,250 | .00 | 0 |
2020-09-25 | STRO | Option Ex | 8,609 | .00 | 0 |
2020-05-14 | STRO | Buy | 6,451 | 7.75 | 49,995 |
2019-09-26 | STRO | Option Ex | 8,608 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-06-09 | PTGX | Option Ex | 10,000 | 8.04 | 80,399 |
2025-06-10 | PTGX | Option Ex | 10,000 | 8.04 | 80,399 |
2025-06-09 | PTGX | Sale | 10,000 | 55.51 | 555,100 |
2025-06-10 | PTGX | Sale | 10,000 | 57.03 | 570,300 |
2025-03-13 | PTGX | Sale | 30,514 | 55.74 | 1,700,850 |
2025-03-13 | PTGX | Option Ex | 30,514 | 31.20 | 952,036 |
2025-01-16 | PTGX | Sale | 3,640 | .00 | 0 |
2024-11-26 | PTGX | Option Ex | 5,529 | 8.04 | 44,453 |
2024-11-27 | PTGX | Option Ex | 26,000 | 8.04 | 209,039 |
2024-11-26 | PTGX | Sale | 5,529 | 45.60 | 252,122 |
2024-11-27 | PTGX | Sale | 26,000 | 44.66 | 1,161,290 |
2024-11-15 | PTGX | Sale | 1,906 | 40.98 | 78,107 |
2023-11-15 | PTGX | Sale | 1,848 | 16.24 | 30,011 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Molina Arturo Md (Chief Medical Officer of Protagonist Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.